Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vir Biotechnology, Inc. - Common Stock
(NQ:
VIR
)
7.430
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vir Biotechnology, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?
↗
February 23, 2026
The company said its current resources are expected to fund operations into the second quarter of 2028.
Via
Stocktwits
Topics
Earnings
Vir Biotechnology (VIR) Earnings Call Transcript
↗
February 23, 2026
Vir Biotechnology (VIR) Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Vir Biotechnology Inc (NASDAQ:VIR) Reports Q4 2025 Revenue Beat and Major Pipeline Updates
↗
February 23, 2026
Via
Chartmill
Is Alnylam Pharmaceuticals a Millionaire Maker?
↗
December 07, 2025
This hot biotech stock could have a lot more room to run.
Via
The Motley Fool
Vir Biotechnology Stock Set For Premarket Surge? Retail Trader Hopes Swell As ‘Phenomenal’ HDV Data Sets Stage For Gilead Showdown
↗
November 09, 2025
Via
Stocktwits
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Earnings Scheduled For May 7, 2025
↗
May 07, 2025
Via
Benzinga
Earnings Outlook For Vir Biotechnology
↗
May 06, 2025
Via
Benzinga
This Astera Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday
↗
August 29, 2025
Via
Benzinga
This Southwest Gas Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
↗
August 29, 2025
Via
Benzinga
This Oddity Tech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
↗
August 28, 2025
Via
Benzinga
This Guess Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
↗
August 28, 2025
Via
Benzinga
5 Analysts Have This To Say About Vir Biotechnology
↗
April 17, 2025
Via
Benzinga
7 Analysts Have This To Say About Vir Biotechnology
↗
February 28, 2025
Via
Benzinga
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
Vir Biotechnology Catapults 62% On Promising Results In Cancer Treatment
↗
January 08, 2025
The company is working to engage the immune system to attack cancer cells.
Via
Investor's Business Daily
This Eli Lilly Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday
↗
August 27, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 27, 2025
Via
Benzinga
Vir (VIR) Q2 Revenue Drops 61%
↗
August 07, 2025
Via
The Motley Fool
12 Health Care Stocks Moving In Friday's After-Market Session
↗
July 11, 2025
Via
Benzinga
Where Vir Biotechnology Stands With Analysts
↗
July 11, 2025
Via
Benzinga
Vir Biotechnology Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
↗
May 22, 2025
Via
Benzinga
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
↗
May 12, 2025
Via
Benzinga
Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why
↗
January 10, 2025
Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate cancer with manageable safety.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
January 08, 2025
Via
Benzinga
Vir Biotechnology Stock Soars On Prostate Cancer Trial Data - Here's Why
↗
January 08, 2025
Vir Biotechnology's Phase 1 trials reveal promising safety and efficacy for dual-masked T-cell engagers targeting HER2 and PSMA in cancer therapies.
Via
Benzinga
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday
↗
January 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
December 03, 2024
Via
Benzinga
AT&T Updates 2024 Outlook, Joins ZJK Industrial, Janux Therapeutics, Credo Technology Group And Other Big Stocks Moving Higher On Tuesday
↗
December 03, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
